Safewill taps into ‘no regrets’ Black Friday and Cyber Monday spree
Australian scale-up Safewill is tapping into the Black Friday/Cyber Monday sales frenzy by urging Australians to spend on something that will give them peace of mind.
Stockhead
New Age drilling to start next week in lithium-rich Pilbara neighbourhood
New Age Exploration is starting a fresh search for LCT pegmatites in the same Pilbara neighbourhood as the Pilgangoora, and Wodgina mines, and the Andover discovery.
‘Strongly positioned to move the business forward’: Race appoints new CEO
Race Oncology’s search for a new CEO has ended with its former chief scientific officer and executive director Dr Daniel Tillett appointed full-time, effective immediately.
Spinal cage joins ASX medical device march
Allegra’s potentially game-changing Cervical Spinal Cage is poised to be the latest in a parade of ASX medical devices becoming success stories.
Stock’s uranium find a ‘geological freak’
A philanthropic investment firm’s conference has been told this ASX stock is sitting on an incredible prospect, just as a uranium bull run picks up speed.
GS thinks lithium may stay in bear trap
Goldman Sachs is at it again, predicting that the lithium bear market may not be over. It believes prices, already depressed, could continue to fall.
The Big V reborn: Advanced rare earths play VHM to reignite forgotten industry
Victoria could soon become a landmark critical rare earths and mineral sands supplier, with VHM launching the countdown towards construction of its flagship Goschen project.
Alterity bags $4.8 million in cap raise
Alterity Therapeutics, a biotech developing treatments for neurodegenerative diseases, has raised $4.8 million in a capital raise. Get your health news here.
Wound care stocks have Morgans rapt
Broker Morgans has lauded three ASX wound care companies, forecasting each will grow revenue by more than 20 per cent for each of the next three years.
With approvals, cash in bag, Norfolk’s path to uranium drilling at Orroroo is now clear
Norfolk Metals is all set to start maiden drilling at its Orroroo uranium project after securing approval from the South Australian Department of Energy and Mining.
End of ‘Argy bargy’ may lift ASX miners
A new business-friendly president who is a huge fan of lithium brings new hope to Argentina – and the ASX stocks operating there, says Peter Strachan.
This company aims to disrupt dairy and infant formula sector … with camel milk
WA-based Good Earth Dairy aims to bring down the price of ‘superfood’ camel milk to make it a viable alternative to cow milk and disrupt the lucrative infant formula sector.
Risks and riches: the two faces of Mali
Mineral-rich West African county Mali can be a challenging place to explore and mine. But these ASX stocks are showing that bravery can be rewarded.
Pure hit of high-grade Swedish lithium
Peggie-poking minnow Pure Resources has ascended the ASX on Tuesday, after heavenly results from Sweden. Get your resources wrap here.
European patent milestone for Painchek
PainChek hasannounced that its pain assessment and monitoring tech is a giant step closer to being protected in Europe. Get your health news here.
Australian solar charging up investors
Choosing solar stocks gives is giving investors a warm glow for several reasons, says Third Hemisphere executive director and Stockhead columnist Jeremy Liddle.
Roots’ innovative cooling tech on display at COP28 after delivery to UAE
Israeli-based Roots has delivered equipment required for its root zone cooling technology to United Arab Emirates customer Silal Food & Technology LLC despite ‘difficult conditions’.
Another 15Tcf in Indonesian waters may make Conrad key regional gas supplier
Conrad Asia Energy could be transformed into a major regional gas supplier, after stunning results from investigations into its Indonesian resources.
Prescient set for big payday, says expert
Pitt Street Research believes Prescient Therapeutics’ potential cancer treatment has a market opportunity ‘at least in the hundreds of millions’.
Lithium heist: ‘We’ve got you surrounded’
Chariot Corp’s ‘surround and conquer’ tactic wrested key land at Black Mountain from a lithium giant. All it cost was $4 million, royalties and someone’s finger.
Striking lift after 4DX gets FDA clearance
Respiratory imaging tech company, 4DMedical jumped by 15 per cent on Monday morning after receiving clearance for its ventilation product from the US FDA.
Colossal find gives Viridis massive boost
Viridis has come out of a trading halt and surged nearly 80 per cent after big assay results from its aptly named Colossus rare earth elements project.
‘Uber for drones’: Aerologix capital raise, acquisition to lift global reach
Australian drone technology start-up Aerologix will use a fresh capital injection to escalate its aggressive global expansion and to launch a new mapping solution.
Tiger Brokers says Aussie investors want access to NASDAQ’s insane gains
The NASDAQ hosts premier tech stocks like Netflix, Apple, Alphabet, Meta, Microsoft, and Nvidia, but Tiger Brokers says plenty of others are popular with Aussie investors.
Newton’s work part of formula for success
Combining the work of Sir Isaac Newton and these three metrics adds up to valuable opportunities for a special class of ASX investor.
St George charged up at Mt Alexander after another battery giant increases stake
nother big-name battery materials investor has upped its stake in St George Mining as interest continues to grow in the company’s Mt Alexander lithium project.
Drugs to aid cancer fight take big steps
Race Oncology’s drug to reduce toxicity from chemotherapy is heading towards human trials after being granted a key approval. Get your health news here.
Cannabis driving test; CBD without THC
Victoria is to launch a cannabis driving trial. Meanwhile, scientists have found a source of cannabidiol which doesn’t come with any THC. Read more in Weed Week.
Microcap with a blue-chip profile: Trajan Group is building strongly
Trajan Group is building its capabilities, as well as enjoying consistent growth and profitability as it develops its global reputation for building industry-leading solutions.
Small caps set to lift their game: analyst
Spheria Asset Management’s Brittany Isakka says small cap stocks are looking stronger. And she’s outlined the sectors and issues investors should consider.
Reborn iron ore junior is aiming high
After rising from the ashes of Flinders Mines, Red Hawk plans to dominate the WA junior iron ore realm, proving the sector is not just about the big boys.
HeraMED maternity care platform delivers
HeraMED jumped more than 30 per cent on Wednesday morning after announcing its clinical trial at Gold Coast Hospital was under way.
IPO Wrap: Wheels fall off early for Chariot
Chariot Corporation certainly wasn’t off to the races at the start of its ASX journey. But another lithium stock is undeterred as it eyes a $12 million IPO.
Private equity deals recovery looming
Private capital raising has endured a fraught year but a rebound seems to be building, and the likes of this ASX stock are ready to leap into action.
Elevate Uranium is going nuclear with 136pc jump in Koppies resource
As a much-anticipated uranium boom arrives, Elevate Uranium has put itself in the best position to capitalise by more than doubling its flagship Koppies resource.
Challenger’s Hualilan a treasure with study outlining low costs, attractive economics
Strong cashflows, potential lowest quartile costs and rapid payback are just some standout features a high-grade starter mine at the Hualilan gold project could deliver to Challenger Gold.
Norwest in search of copper paradise at Bali project in WA
Norwest Minerals is back on the ground at its Bali copper project in the Ashburton region of WA, with the first RC holes set to be drilled into two “highly prospective” targets.
The Force is with Alderan
Alderan Resources has been among stellar performers on the ASX on Tuesday – even if the reason for that is not absolutely clear. Get your resources news here.
New outlook for prostate cancer detection
Technology that has potential to change how prostate cancer is detected and treated has hit a milestone, with 50 patients imaged in a Phase 2 trial.
Aurelia may have golden future: FitzGerald
After a massive acquisition deal for one of its neighbours, Aurelia Metals looks enticing to veteran mining columnist Barry FitzGerald. Here’s why.
Broker likes Silk’s road, takes shine to Shine
Broker MA Moelis sees success ahead for Silk Logistics and judges Shine Justice to be at an ‘inflection point’ – slapping Buy ratings on each.
Aussie stocks ready for a China charge
With Prime Minister Anthony Albanese on a charm offensive in China, these ASX stocks are poised to benefit from a warmer view of Aussie products and services.
Buxton rolling in high-grade nickel at Dogleg
Buxton Resources’ share price gained new bite after exciting news about nickel sulphide finds at its Dogleg prospect. Get your resources wrap here.
PYC and FDA seeing eye-to-eye
PYC Therapeutics’ drug to treat a blinding disease is heading to human trials after agreement between the company and the US FDA.
Backing biotechs can pay off in long run
Investors are often nervous about drug developers on a long path to approval, but the benefits can be huge for both patients and share prices, says Tim Boreham.
Trend the momentum investor’s friend
Here’s Hot Monday Money, Stockhead’s weekly look at ASX small cap stocks that are showing signs of value for momentum investors.
New metric turns up heat on ASX stocks
With no ASX stock on course to hit its net-zero target, a new acronym set to appear on funds returns could be a major signpost for ethical investors.
Making a dent in copper supply deficit
Amid industry experts’ dire warnings of a looming copper supply deficit, these ASX stocks are putting in the hard yards to bring new projects online.
MC Mining hosts game of musical chairs
Embattled ASX coking coal producer MC Mining is up 50 per cent after two of its largest shareholders launched a takeover bid. Here’s your resources wrap.
DAYBUE hits heights in monster quarter
Great news for two ASX biotechs, with Neuren Pharma almost tripling its DAYBUE sales in a quarter and Argenica’s shares soaring by 40 per cent.
Original URL: https://www.heraldsun.com.au/business/stockhead/page/50